ReviewInvestigative ophthalmology & visual science2021
IMI 2021 Reports and Digest - Reflections on the Implications for Clinical Practice.
Review in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Effects of repeated low-level red light therapy on myopia progression in children: a systematic review and meta-analysis.Frontiers in medicine · 2025Pooled it
- Effectiveness of repeated low-level red light in myopia prevention and myopia control.The British journal of ophthalmology · 2024Trial
- The growing burden of myopia in Europe: evidence from population-based cohorts.European journal of epidemiology · 2026Article
- Is AI Redefining Scientific Publications?Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Article
- Localized Choriocapillaris Flow Deficits at Perforating Vessel Sites in Myopic Eyes.Investigative ophthalmology & visual science · 2026Article
- Control effect of dual-mechanism myopia control lenses on myopia in children and adolescents: a prospective, 12-month, non-randomized, parallel-controlled, and single-center trial protocol.Frontiers in medicine · 2026Article
- Changes in eye axis length and corneal curvature in central China from the perspective of birth year.Eye (London, England) · 2025Article
- Key strategies to reduce the global burden of myopia: consensus from the international myopia summit.The British journal of ophthalmology · 2025Review
- Chinese parents' knowledge, attitude, and practice of myopia control: 2023 update.BMC public health · 2025Article
- Scoping Review of the Role of Accommodation and Binocular Coordination in Myopia Onset and Progression.Clinical ophthalmology (Auckland, N.Z.) · 2025Review
- Effects of Acute Mental Stress on Choroidal Thickness.Bioengineering (Basel, Switzerland) · 2024Article
- Myopia Control: Are We Ready for an Evidence Based Approach?Ophthalmology and therapy · 2024Review
- The causal mutation in ARR3 gene for high myopia and progressive color vision defect.Scientific reports · 2023Article
- Editorial: International Myopia Institute White Paper Series 2023.Investigative ophthalmology & visual science · 2023Article
- IMI-Global Trends in Myopia Management Attitudes and Strategies in Clinical Practice-2022 Update.Investigative ophthalmology & visual science · 2023Article
- Beijing Pinggu Childhood Eye Study: The Baseline Refractive Characteristics in 6- to 12-Year-Old Chinese Primary School Students.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The International Myopia Institute's (IMI) mission is to advance research, education, and management of myopia to decrease future vision impairment and blindness associated with increasing myopia. Its approach is to bring together scientists, clinicians, policymakers, government members, and educators into the field of myopia to stimulate collaboration and sharing of knowledge. The latest reports are on pathologic myopia, the impact of myopia, risk factors for myopia, accommodation and binocular vision in myopia development and progression, and the prevention of myopia and its progression. Together with the digest updating the 2019 International Myopia Institute white papers using the research published in the last 18 months, these evidence-based consensus white papers help to clarify the imperative for myopia control and the role of environmental modification initiatives, informing an evidence-based clinical approach. This guidance includes who to treat and when to start or stop treatment, and the advantages and limitations of different management approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.